Standard of care treatment clinical trials
4 indexed studies · 3 currently recruiting
- RecruitingPHASE3
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
This study is looking at a new medicine called nipocalimab for adults with moderate to severe lupus. It compares nipocalimab to a dummy treatment (placebo) to see if it can help reduce inflammation and improve lupus symptoms.
For: Lupus Erythematosus, SystemicUnited States · Argentina · Australia - Active not recruitingPHASE3
Nipocalimab in Moderate to Severe Sjogren's Disease
This study is testing a new drug called nipocalimab for people with moderate to severe Sjögren's disease. Researchers want to see if it's safe and effective compared to a dummy treatment (placebo) alongside their usual care.
For: Sjogrens SyndromeUnited States · Argentina · Austria - Not yet recruitingNA
SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's Disease
This study looks at whether smartwatches can help people with Parkinson's better manage their symptoms. It compares regular care to care with a smartwatch and app, hoping to give doctors a clearer picture of how symptoms change throughout the day to improve treatment.
For: Parkinson Disease, IdiopathicCanada - RecruitingPHASE2, PHASE3
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
This study is testing a new cell therapy called KYV-101 for people with a type of muscle weakness called myasthenia gravis. It aims to see if this therapy, which targets specific immune cells, can help reduce symptoms and improve daily life for patients.
For: Myasthenia Gravis · Generalized Myasthenia GravisUnited States · Australia · Brazil